NDC 69168-371

Senna Lax

Sennosides 8.6mg

Senna Lax is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Allegiant Health. The primary component is Sennosides.

Product ID69168-371_25c04058-9d3a-4bd9-916a-c2c767e4b1d3
NDC69168-371
Product TypeHuman Otc Drug
Proprietary NameSenna Lax
Generic NameSennosides 8.6mg
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2014-07-01
Marketing End Date2021-12-30
Marketing CategoryOTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL
Application Numberpart334
Labeler NameAllegiant Health
Substance NameSENNOSIDES
Active Ingredient Strength9 mg/1
NDC Exclude FlagN

Packaging

NDC 69168-371-30

30 TABLET in 1 BOTTLE (69168-371-30)
Marketing Start Date2014-07-01
Marketing End Date2021-12-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 69168-371-30 [69168037130]

Senna Lax TABLET
Marketing CategoryOTC MONOGRAPH NOT FINAL
Application Numberpart334
Product TypeHUMAN OTC DRUG
Marketing Start Date2014-07-01
Marketing End Date2021-12-30

Drug Details

Active Ingredients

IngredientStrength
SENNOSIDES8.6 mg/1

NDC Crossover Matching brand name "Senna Lax" or generic name "Sennosides 8.6mg"

NDCBrand NameGeneric Name
69168-371Senna LaxSennosides 8.6mg
76162-005Senna LaxSennosides 8.6mg

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.